Eli Lilly and Company has partnered with OpenAI to leverage OpenAIs generative AI technology for developing new antimicrobial treatments to combat drugresistant pathogens Antimicrobial resistance
Shanghai Junshi Biosciences Co Ltd a leading biopharmaceutical company focused on innovation has received approval from Chinas National Medical Products Administration
Porton Advanced has recently integrated the MaxCyte cGMPgrade ExPERT GTx Flow Electroporation instrument into its cell therapy platform making it the first cell therapy CDMO in China
ILiAD Biotechnologies LLC a biotechnology company focused on combating diseases caused by Bordetella
Biond Biologics Ltd a clinicalstage biopharmaceutical company specializing in cancer immunotherapy has initiated its firstinhuman clinical trial of BND a humanized ILTLILRB antagonist antibody The trial commenced with the dosing of its first patient at the Institute of Oncology Davidoff Center Rabin...
GSK plc announced today that Omjjara has received approval from Japans Ministry of Health Labour and Welfare for treating myelofibrosis Omjjara is an oral inhibitor of JAKJAK and activin A receptor type
Hyundai Bioscience which is preparing for a dengue fever basket clinical trial in Brazil announced on the th that it has successfully developed a multitreatment drug for mosquitoborne viral infections
Capricor Therapeutics a biotechnology company developing transformative cell and exosomebased therapeutics for the treatment of rare diseases today announced
Charles River Laboratories International Inc and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract development and manufacturing
BioAI an emerging biotech company applying multimodal artificial intelligence to novel biomarker
Bota Bio a global industrial biotechnology company specializing in sustainable biomanufacturing solutions and NHU a global leader in the fine chemical industry have announced the successful commercialization
Sun Pharmaceutical Industries Limited today announced the successful completion of the merger of Taro Pharmaceutical Industries Ltd with its subsidiary As part of this merger Sun Pharma acquired all outstanding ordinary shares of Taro other than the shares already held by Sun Pharma or its affiliate...
Incheon, South Korea
Suntec Convention & Exhibition Centre, Singapore
Basel, Switzerland
Boston, MA, USA
Singapore
Tokyo, Japan
Boston, MA, USA
Jakarta Barat, Indonesia
Assistant Manager - Medical Affairs and Pharmacovigilance, Unichem Laboratories Ltd.
President, Global Critical Care, Venus Remedies Ltd, and CEO, Venus Medicine Research Centre
Department of Microbiology, St. Pius X College
Professor, Department of Pharmaceutics, St. Paul's College of Pharmacy
Professor, Department of Pharmaceutical Chemistry, Sri Shivani College of Pharmacy
Professor, Department of Pharmacology, St.Paul's College of Pharmacy
Staff Engineer, Manufacturing Science and Technology, South East Asia
Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshooting and technical training for downstream processes Chan holds a degree in Chemical Engineering from the National University of SingaporeIn field of Nanotechnology and Nano medicine there are large number of nanomaterials are used to deliver drug having properties like improving solubility extending formulations action different degrees of lipophilicity or hydrophilicity less toxicity and many more Chitosan based nanoparticles have been various applications
AbstractIn December of chikungunya virus CHIKV an alphavirus in the family Togaviridae was introduced to the island of Saint Martin in the Caribbean resulting in the first autochthonous cases reported in the Americas As of January local and imported CHIKV has been reported in American countries with over million suspected cases CHIKV c
This study shows how to obtain elegant uniform coatings with zero visible defects and a practical coating solution for heat sensitive productsFor More Infromation Click Here
UVA Healths research has unveiled the potential of vorasidenib in treating grade IDHmutant gliomas This discovery marks a significant stride in identifying a promising drug that will positively impact patients
Should pharmaceutical companies augment their offshore strategies by performing some clinical trials in lowercost locations The short answer is yes Emerging markets offer faster time to market reduced costs and the same high quality that companies demand But which countries present the best opportunities China India and Russia top the list according to AT Kearneys Country Attractiveness Index for...
Approximately million people worldwide are living with a rare disease and about half of those affected by rare diseases are children
Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevic...
Drug development has transformed immeasurably over the past decade Even before the Covid pandemic and the conflict in Ukraine
Many advanced largescale AI initiatives still need to be proved successful in Pharma
Singapore has had a multidecade longterm vision for building a worldclass biomedical cluster